Fischer Medical Ventures Limited Stock Price Today (NSE: FISCHER)
Fundamental Score
Fischer Medical Ventures Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Fischer Medical Ventures Limited share price today is ₹33.50, down 1.53% on NSE/BSE as of 16 September 2026. Fischer Medical Ventures Limited (FISCHER) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹2.19K (Cr). The 52-week high for FISCHER share price is ₹124.70 and the 52-week low is ₹31.05. At a P/E ratio of 13.96x, FISCHER is currently trading below its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 8.59% and a debt-to-equity ratio of 0.19.
Fischer Medical Ventures Limited Share Price Chart — NSE/BSE Historical Performance
Fischer Medical Ventures Limited share price chart: -8.77% return over the past month. 52-week high ₹124.70, 52-week low ₹31.05.
Fischer Medical Ventures Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹34.70 | ₹34.71 | ₹32.96 | ₹33.50 | 3.66L (Cr) | |
| ₹35.95 | ₹35.98 | ₹33.70 | ₹34.02 | 3.01L (Cr) | |
| ₹35.29 | ₹36.14 | ₹33.68 | ₹35.87 | 5.80L (Cr) | |
| ₹35.01 | ₹35.55 | ₹34.59 | ₹34.90 | 4.52L (Cr) | |
| ₹36.00 | ₹36.01 | ₹34.50 | ₹34.78 | 6.69L (Cr) | |
| ₹35.71 | ₹36.29 | ₹35.40 | ₹35.56 | 3.00L (Cr) | |
| ₹36.34 | ₹36.34 | ₹35.50 | ₹35.72 | 2.51L (Cr) | |
| ₹37.44 | ₹37.62 | ₹35.80 | ₹36.04 | 3.30L (Cr) | |
| ₹38.25 | ₹38.50 | ₹36.75 | ₹37.03 | 4.48L (Cr) | |
| ₹37.67 | ₹38.00 | ₹36.76 | ₹37.73 | 6.51L (Cr) |
Fischer Medical Ventures Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹35.48 | ₹38.50 | ₹32.96 | ₹33.50 | -5.58% | |
| ₹38.13 | ₹39.95 | ₹34.89 | ₹35.21 | -7.66% | |
| ₹41.90 | ₹42.37 | ₹35.36 | ₹39.13 | -6.61% | |
| ₹36.24 | ₹42.11 | ₹31.05 | ₹41.72 | +15.12% | |
| ₹37.96 | ₹39.77 | ₹33.33 | ₹38.14 | +0.47% | |
| ₹42.47 | ₹42.78 | ₹36.60 | ₹37.96 | -10.62% | |
| ₹37.06 | ₹40.69 | ₹32.01 | ₹40.50 | +9.28% | |
| ₹37.39 | ₹46.43 | ₹35.70 | ₹38.26 | +2.33% | |
| ₹42.30 | ₹43.70 | ₹33.94 | ₹38.51 | -8.96% | |
| ₹48.94 | ₹50.48 | ₹41.00 | ₹41.62 | -14.96% | |
| ₹119.29 | ₹119.40 | ₹40.79 | ₹48.08 | -59.69% | |
| ₹112.10 | ₹121.70 | ₹91.53 | ₹117.71 | +5.00% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Fischer Medical Ventures Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Fischer Medical Ventures Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of FISCHER across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 13.96 vs Industry: 36.70)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (249.42%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.19)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.99x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 4.48)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (61.80%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
4 factors identified
Below-Average Return on Equity (8.59%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-24.30%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-247.60 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 6.35%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Fischer Medical Ventures Limited vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Fischer Medical Ventures Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Fischer Medical Ventures LimitedFischer Medical...Selected✓ FISCHER • 524743 | 21.9/100 | ₹33.50₹34 | ₹2192.63₹2192.63 | 13.96Average 14.0 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.19Excellent 0.2 Excellent | — — | — — | 0.01% |
Poly Medicure LimitedPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1732.30₹1732 | ₹17558.49₹17558.49 | 55.72Average 55.7 Average | 10.97%Average 10.97% Average | 14.28%Average 14.28% Average | 0.11Excellent 0.1 Excellent | 18.85%Excellent 18.85% Excellent | 18.98%Excellent 18.98% Excellent | 0.20% |
Tarsons Products LimitedTarsons Product... TARSONS • 543399 | 17.1/100 | ₹318.70₹319 | ₹1695.64₹1695.64 | 152.49Average 152.5 Average | 0.00%Poor 0.00% Poor | 4.87%Poor 4.87% Poor | 0.60Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LimitedLaxmi Dental Li... LAXMIDENTL • 544339 | 69.6/100 | ₹200.47₹200 | ₹1101.78₹1101.78 | 35.42Average 35.4 Average | 12.83%Average 12.83% Average | 12.34%Average 12.34% Average | 0.00Excellent 0.0 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹369.90₹370 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹463.00₹463 | ₹603.68₹603.68 | 30.06Average 30.1 Average | 18.16%Good 18.16% Good | 24.15%Excellent 24.15% Excellent | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹385.90₹386 | ₹463.20₹463.20 | 20.32Average 20.3 Average | 18.60%Good 18.60% Good | 23.74%Excellent 23.74% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
Nureca LimitedNureca Limited... NURECA • 543264 | 16.5/100 | ₹334.00₹334 | ₹318.70₹318.70 | 77.67Average 77.7 Average | 0.00%Poor 0.00% Poor | 3.30%Poor 3.30% Poor | 0.00Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹152.20₹152 | ₹294.32₹294.32 | 30.87Average 30.9 Average | 10.45%Average 10.45% Average | 19.30%Good 19.30% Good | 0.65Good 0.7 Good | — — | — — | 0.45% | |
38.2/100 | ₹103.25₹103 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
32.1/100 | ₹150.00₹150 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Limited share price17558.49 Cr
- Tarsons Products Limited share price1695.64 Cr
- Laxmi Dental Limited share price1101.78 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
- HSIL Limited share price603.68 Cr
Fischer Medical Ventures Limited PE Ratio History
Historical price-to-earnings ratio for FISCHER — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.22 | ₹41.62 | 189.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Fischer Medical Ventures Limited Quarterly Performance
Latest quarterly metrics for FISCHER — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
249.42%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-24.30%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Fischer Medical Ventures Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for FISCHER — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Fischer Medical Ventures Limited Financial Statements
Annual income statement, balance sheet and cash flow for Fischer Medical Ventures Limited (FISCHER) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Fischer Medical Ventures Limited
About FISCHER (Fischer Medical Ventures Limited)
Fischer Medical Ventures Ltd is a dynamic force in the medical equipment and supplies sector, dedicated to innovating and delivering comprehensive healthcare solutions across India... and beyond. As a multifaceted company, Fischer integrates manufacturing, distribution, leasing, and maintenance services to provide a seamless experience for its diverse clientele. Going beyond conventional offerings, Fischer is committed to addressing critical healthcare challenges through its wide-ranging portfolio encompassing advanced imaging technologies, cutting-edge screening tools, and pioneering digital health platforms. With a focus on preventative and diagnostic care, Fischer Medical Ventures strives to make a tangible impact on patient outcomes and improve access to quality healthcare. At the heart of Fischer's innovative approach lies its commitment to leveraging technology for the betterment of healthcare. Their product suite showcases a range of advanced diagnostic equipment, including sophisticated magnetic resonance imaging (MRI) and computed tomography (CT) systems. Fischer also champions proactive health management through its preventative health kiosks and e-health access points. Furthermore, their focus is evident in the range of handheld X-ray devices for cancer and TB screening, demonstrating their dedication to making healthcare solutions accessible and effective. By embracing forward-thinking solutions, Fischer Medical Ventures is driving advancements in diagnostics and preventative care for a healthier future. Fischer Medical Ventures distinguishes itself by seamlessly blending medical technology with holistic wellness solutions. This unique approach extends beyond equipment to include innovative health monitoring technologies like spincare, nutraceuticals derived from plant extracts, and mental health solutions. The company is also at the forefront of contactless screening solutions, adapting to the evolving needs of healthcare environments. This integrated approach reinforces Fischer's commitment to providing comprehensive, accessible, and technologically advanced solutions that address a wide spectrum of healthcare needs and improves the quality of life for individuals and communities.
Company Details
Key Leadership
FISCHER Share Price: Frequently Asked Questions
What is the current share price of Fischer Medical Ventures Limited?
Fischer Medical Ventures Limited (FISCHER) trades at ₹33.50 on NSE and BSE. Market cap ₹2.19K (Cr). Educational data only.
What is the P/E ratio of Fischer Medical Ventures Limited?
Fischer Medical Ventures Limited has a P/E of 13.96x vs industry average 36.70x.
What is the Bull Run score for Fischer Medical Ventures Limited?
Fischer Medical Ventures Limited has a Bull Run score of 21.9/100 based on 25+ financial parameters.
Does Fischer Medical Ventures Limited pay dividends?
Fischer Medical Ventures Limited has a dividend yield of 0.01%. Past dividends don't guarantee future payments.
What is the ROE of Fischer Medical Ventures Limited?
Fischer Medical Ventures Limited has ROE of 8.59%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Fischer Medical Ventures Limited?
Fischer Medical Ventures Limited has debt-to-equity of 0.19.
Is Fischer Medical Ventures Limited a good investment?
Bull Run gives Fischer Medical Ventures Limited a score of 21.9/100. This is not investment advice — consult a SEBI-registered advisor.